Abstract
Adenosine (10-9-10-6 mol/l) and R-phenylisopropyladenosine (10-9-10-7 mol/l) partially inhibited the intracellular accumulation of cyclic AMP induced by isoproterenol, prostaglandin E1, histamine and 5′-N-ethylcarboxamidoadenosine in lymphocytes. In contrast, S-phenylisopropyladenosine, which is a poor agonist of the adenosine A1/Ri receptor, had essentially no inhibitory effect. 8-Phenyltheophylline, in low concentrations that do not inhibit cyclic AMP phosphodiesterase, completely blocked the inhibitory effect of R-phenylisopropyladenosine on the increase in cyclic AMP induced by prostaglandin E1. R-Phenylisopropyladenosine (10-8-10-6 mol/l) also inhibited the cyclic AMP accumulation in lymphocytes induced by forskolin (10-5 mol/l), which activates adenylate cyclase through direct interaction with the enzyme. We also investigated the presence of the adenosine A1/Ri receptor on human polymorphonuclear leukocytes. R-Phenylisopropyladenosine (3×10-9-10-7 mol/l) abolished the stimulating effects of prostaglandin and forskolin on cyclic AMP accumulation in polymorphonuclear leukocytes. This effect was blocked by 8-phenyltheophylline and was not observed with the stereoisomer S-phenylisopropyladenosine. The results support the existence of an A1/Ri receptor that regulates cyclic AMP metabolism of human lymphocytes and polymorphonuclear leukocytes.
Original language | English (US) |
---|---|
Pages (from-to) | 235-242 |
Number of pages | 8 |
Journal | International Journal of Clinical and Laboratory Research |
Volume | 22 |
Issue number | 1-4 |
DOIs | |
State | Published - Mar 1992 |
Externally published | Yes |
Keywords
- A/R receptor
- Adenosine
- Cyclic AMP
- Lymphocytes
- Polymorphonuclear leukocytes
ASJC Scopus subject areas
- Clinical Biochemistry